http://www.unboundmedicine.com/medline/ebm/research/rabeprazoleUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19916375/full_citation/Spectrofluorometry_thin_layer_chromatography_and_column_high_performance_liquid_chromatography_determination_of_rabeprazole_sodium_in_the_presence_of_its_acidic_and_oxidized_degradation_products_Osman A, Osman M 
Spectrofluorometry, thin layer chromatography, and column high-performance liquid chromatography determination of rabeprazole sodium in the presence of its acidic and oxidized degradation products. [Journal Article]
J AOAC Int 2009 Sep-Oct; 92(5):1373-81.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19889069/full_citation/The_modified_sequential_treatment_regimen_containing_levofloxacin_for_Helicobacter_pylori_eradication_in_Turkey_Aydin A, Oruc N, Turan I, et al. 
The modified sequential treatment regimen containing levofloxacin for Helicobacter pylori eradication in Turkey. [Journal Article]
Helicobacter 2009 Dec; 14(6):520-4.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19888786/full_citation/Patient_satisfaction_with_switching_to_esomeprazole_from_existing_proton_pump_inhibitor_therapy_for_gastro_oesophageal_reflux_disease:_an_observational_multicentre_study_Hoogendoorn RJ, Groeneveld L, Kwee JA 
Patient satisfaction with switching to esomeprazole from existing proton pump inhibitor therapy for gastro-oesophageal reflux disease: an observational, multicentre study. [Journal Article]
Clin Drug Investig 2009; 29(12):803-10.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19881258/full_citation/Absence_of_Influence_of_Concomitant_Administration_of_Rabeprazole_on_the_Pharmacokinetics_of_Tacrolimus_in_Adult_Living_donor_Liver_Transplant_Patients:_A_Case_Control_Study_Hosohata K, Masuda S, Yonezawa A, et al. 
Absence of Influence of Concomitant Administration of Rabeprazole on the Pharmacokinetics of Tacrolimus in Adult Living-donor Liver Transplant Patients: A Case-Control Study. [Journal Article]
Drug Metab Pharmacokinet 2009; 24(5):458-63.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19860005/full_citation/Efficacy_and_safety_of_rabeprazole_in_non_steroidal_anti_inflammatory_drug_induced_ulcer_in_Japan_Mizokami Y 
Efficacy and safety of rabeprazole in non-steroidal anti-inflammatory drug-induced ulcer in Japan. [JOURNAL ARTICLE]
World J Gastroenterol 2009 Oct 28; 15(40):5097-5102.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19856792/full_citation/Pharmacokinetics_and_bioequivalence_study_of_a_fixed_dose_combination_of_rabeprazole_and_itopride_in_healthy_Indian_volunteers_Sahoo BK, Das A, Agarwal S, et al. 
Pharmacokinetics and bioequivalence study of a fixed dose combination of rabeprazole and itopride in healthy Indian volunteers. [Journal Article]
Arzneimittelforschung 2009; 59(9):451-4.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19844108/full_citation/Geranylgeranylacetone_Protects_against_Diclofenac_Induced_Gastric_and_Small_Intestinal_Mucosal_Injuries_in_Healthy_Subjects:_A_Prospective_Randomized_Placebo_Controlled_Double_Blind_Cross_Over_Study_Niwa Y, Nakamura M, Miyahara R, et al. 
Geranylgeranylacetone Protects against Diclofenac-Induced Gastric and Small Intestinal Mucosal Injuries in Healthy Subjects: A Prospective Randomized Placebo-Controlled Double-Blind Cross-Over Study. [JOURNAL ARTICLE]
Digestion 2009 Oct 16; 80(4):260-266.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19827531/full_citation/[Combined_therapy_of_acid_dependent_gastrointestinal_disorders_with_the_use_of_antacidic_drug_Relcer][Combined therapy of acid-dependent gastrointestinal disorders with the use of antacidic drug Relcer] [English Abstract, Journal Article]
Klin Med (Mosk) 2009; 87(8):48-52.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19824113/full_citation/Long_term_treatment_with_proton_pump_inhibitor_is_associated_with_undesired_weight_gain_Yoshikawa I, Nagato M, Yamasaki M, et al. 
Long-term treatment with proton pump inhibitor is associated with undesired weight gain. [Journal Article]
World J Gastroenterol 2009 Oct 14; 15(38):4794-8.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19714973/full_citation/High_performance_thin_layer_chromatographic_determination_of_rabeprazole_sodium_and_domperidone_in_combined_dosage_form_Gandhi SV, Khan SI, Jadhav RT, et al. 
High-performance thin-layer chromatographic determination of rabeprazole sodium and domperidone in combined dosage form. [Journal Article]
J AOAC Int 2009 Jul-Aug; 92(4):1064-7.
Abstract | Full Citation | Find Related Articles